Dr. Reddy's Laboratories Limited
DRREDDY
Rangering i aksjer
#1915
Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's... Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's Laboratories Limited functions as a fully integrated global pharmaceutical entity. Its business is structured into several core divisions. The Global Generics segment is responsible for the production and distribution of prescription and over-the-counter finished pharmaceutical products, marketed either under their own brand names or as generic versions therapeutically equivalent to branded formulations, also encompassing biologics. The Pharmaceutical Services and Active Ingredients (PSAI) division manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates, which are fundamental components for finished drugs, alongside offering contract research services and custom production of APIs and steroids. The Proprietary Products segment is dedicated to the research and development of unique and differentiated drug formulations. Furthermore, its "Others" segment focuses on developing treatments for oncology and inflammatory conditions. The company's therapeutic reach spans numerous areas including gastro-intestinal, cardiovascular, anti-diabetic, dermatological, oncology, respiratory, stomatological, urological, and nephrological health. Dr. Reddy's also maintains a strategic collaboration with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists for immuno-oncology and precision oncology applications.
Aksjekurs
$13.03
Markedsverdi
$10.86B
Endring (1 dag)
-4.70%
Endring (1 år)
-10.97%
Land
IN
Handel Dr. Reddy's Laboratories Limited (DRREDDY)
Kategori
Healthcare
Inntekter for Dr. Reddy's Laboratories Limited (DRREDDY)
Inntekter i Oct 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Dr. Reddy's Laboratories Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Dr. Reddy's Laboratories Limited fra 2001 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2009 | $1.37B | 9.46% |
| 2008 | $1.25B | -16.98% |
| 2007 | $1.51B | 175.55% |
| 2006 | $546.26M | 22.50% |
| 2005 | $445.93M | -3.81% |
| 2004 | $463.60M | 22.55% |
| 2003 | $378.29M | 11.12% |
| 2002 | $340.43M | 44.70% |
| 2001 | $235.27M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
